Vitamin E succinate shown to control tumor growth and enhance immunotherapy effects

High levels of fat mass and obesity-associated protein (FTO) have been linked to increased tumor growth and resistance to immunotherapy. In a study recently published in the Proceedings of the National Academy of Sciences, researchers from the University of Chicago Medicine have identified vitamin E succinate (VES) as an effective agent in controlling tumor growth by promoting the degradation of FTO.